Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Q32 Bio (QTTB) Revenue (2018 - 2023)

Q32 Bio (QTTB) has 6 years of Revenue data on record, last reported at $5.5 million in Q4 2023.

  • For Q4 2023, Revenue rose 585.16% year-over-year to $5.5 million; the TTM value through Sep 2024 reached $5.5 million, down 37.65%, while the annual FY2025 figure was $53.7 million, N/A changed from the prior year.
  • Revenue reached $5.5 million in Q4 2023 per QTTB's latest filing, up from $1.9 million in the prior quarter.
  • Across five years, Revenue topped out at $29.3 million in Q1 2021 and bottomed at $270000.0 in Q1 2019.
  • Average Revenue over 5 years is $2.8 million, with a median of $802000.0 recorded in 2021.
  • Peak YoY movement for Revenue: skyrocketed 4883.84% in 2021, then plummeted 97.26% in 2022.
  • A 5-year view of Revenue shows it stood at $563000.0 in 2019, then soared by 74.07% to $980000.0 in 2020, then dropped by 18.16% to $802000.0 in 2021, then changed by 0.0% to $802000.0 in 2022, then surged by 585.16% to $5.5 million in 2023.
  • Per Business Quant database, its latest 3 readings for Revenue were $5.5 million in Q4 2023, $1.9 million in Q3 2023, and $3.2 million in Q2 2023.